نتایج جستجو برای: raeb

تعداد نتایج: 214  

Journal: :Blood 1990
C Denzlinger A Kapp M Grimberg H H Gerhartz W Wilmanns

The hematopoietic cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) is being used in clinical trials for its potential in the treatment of hematopoietic insufficiency due to various causes. Involvement of leukotrienes in the effects of GM-CSF is suggested by analytical and pharmacologic evidence obtained in vitro. However, until now no data in support of a role of leukotrienes ...

Journal: :Stem cell research 2015
F G J Calkoen C Vervat M van Pel V de Haas L S Vijfhuizen E Eising W G M Kroes P A C 't Hoen M M van den Heuvel-Eibrink R M Egeler M J D van Tol L M Ball

Pediatric myelodysplastic syndrome (MDS) is a heterogeneous disease covering a spectrum ranging from aplasia (RCC) to myeloproliferation (RAEB(t)). In adult-type MDS there is increasing evidence for abnormal function of the bone-marrow microenvironment. Here, we extensively studied the mesenchymal stromal cells (MSCs) derived from children with MDS. MSCs were expanded from the bone-marrow of 17...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Lan Xu Zhao-Hui Gu Yang Li Jin-Li Zhang Chun-Kang Chang Chun-Ming Pan Jing-Yi Shi Yang Shen Bing Chen Yue-Ying Wang Lu Jiang Jing Lu Xin Xu Jue-Ling Tan Yu Chen Sheng-Yue Wang Xiao Li Zhu Chen Sai-Juan Chen

Myelodysplastic syndrome (MDS) includes a group of diseases characterized by dysplasia of bone marrow myeloid lineages with ineffective hematopoiesis and frequent evolution to acute myeloid leukemia (AML). Whole-genome sequencing was performed in CD34(+) hematopoietic stem/progenitor cells (HSPCs) from eight cases of refractory anemia with excess blasts (RAEB), the high-risk subtype of MDS. The...

Journal: :The oncologist 1997
Tohyama Tsutani Wano Iwasaki Fukushima Urasaki Kawai Nakamura Yoshida Ueda

We evaluated the outcome of anti-leukemia chemotherapy on 42 patients with the high-risk myelodysplastic syndromes (MDS)-refractory anemia with excess of blasts (RAEB), 8 cases; RAEB in transformation (RAEB-T), 18 cases; chronic myelomonocytic leukemia (CMMOL), 6 cases; and leukemic transformation of MDS, 10 cases. The median age was 67 (range 20 to 84). As a remission-induction therapy, 35 pat...

Journal: :Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2009
Abdalla Awidi Ahmad Magableh Ziad Taimeh Hashim Ayyad Nazzal Bsoul Musleh Tarawneh

OBJECTIVE Study of the disease patterns and clinical evaluation of myelodysplastic syndrome (MDS). SUBJECTS AND METHODS A retrospective analysis was carried out on 85 patients, with MDS who were followed up over a period of 23 years at Jordan University Hospital, Amman, Jordan. Cases were analyzed according to the French, American and British Classification. RESULTS Of the 85 patients, 42 (...

Journal: :Journal of clinical pathology 1987
W N Erber A Jacobs D G Oscier A M O'Hea D Y Mason

The alkaline phosphatase-antialkaline phosphatase (APAAP) immunocytochemical staining technique was used to look for circulating cells of megakaryocyte lineage in peripheral blood smears from 67 cases of myelodysplasia. Small numbers of micromegakaryocytes positive for platelet glycoprotein IIIa were found in 23 cases. These cells superficially resemble small lymphoid cells and are hence diffic...

2015
Régis T. Costello Amélie Leclercq Thérèse Le Treut Carole Sanchez Delphine Mercier Gérard Sébahoun

Epigenetic drugs modify DNA methylation and are used in refractory anemia with excess of blasts (RAEB). These drugs may reactivate anti-oncogene expression and restore a normal phenotype instead of inducing antitumor toxicity, although they also have immunosuppressive effects on T-lymphocytes [1] In RAEB and acute myeloid leukemia, a defect in natural killer (NK) cell cytotoxicity has been show...

2015
Pavel Majek Klara Pecankova Jaroslav Cermak Jan E. Dyr

In recent years the plasma proteomes of several different myelodysplastic syndrome (MDS) subgroups have been investigated and compared with those of healthy donors. However, the resulting data do not facilitate a direct and statistical comparison of the changes among the different MDS subgroups that would be useful for the selection and proposal of diagnostic biomarker candidates. The aim of th...

Journal: :Leukemia research 2009
Katsuya Yamamoto Atsuo Okamura Yoshio Katayama Manabu Shimoyama Toshimitsu Matsui

We describe here two cases of myelodysplastic syndrome (MDS) with a novel unbalanced translocation der(5;19)(p10;q10). Both patients had complex karyotypes including der(5;19) accompanied by an extra chromosome 19, resulting in deletion of the whole long arm of chromosome 5. Furthermore, these patients presented several common clinical and hematological characteristics: MDS subtypes as refracto...

Journal: :East African medical journal 1989
J M Mukiibi B Paul

Twenty three Zimbabwean African patients who satisfied the French-American-British(FAB) diagnostic criteria for the myelodysplastic syndromes(MDS) at Godfrey Huggins School of Medicine, University of Zimbabwe, between July 1985 and June 1987 are presented. The disorders appear not to behave differently from those reported in Caucasian populations with regard to clinical and haematological featu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید